Cluster randomized trial of an active, multifaceted information dissemination intervention based on The WHO Reproductive health library to change obstetric practices: methods and design issues [ISRCTN14055385] by Gülmezoglu, A Metin et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Medical Research 
Methodology
Open Access Research article
Cluster randomized trial of an active, multifaceted information 
dissemination intervention based on The WHO Reproductive 
health library to change obstetric practices: methods and design 
issues [ISRCTN14055385]
A Metin Gülmezoglu*1, José Villar1, Jeremy Grimshaw2, Gilda Piaggio1, 
Pisake Lumbiganon3 and Ana Langer4
Address: 1UNDP/UNFPA/WHO/World Bank Special Programme on Research, Development and Research Training in Human Reproduction 
(HRP), Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland, 2Ottawa Health Research Institute, 
Clinical Epidemiology Program, Ottawa, Canada, 3Khon Kaen University, Department of Obstetrics and Gynaecology, Faculty of Medicine, Khon 
Kaen, Thailand and 4Population Council, Regional Office for Latin America and the Caribbean, Mexico D.F., Mexico
Email: A Metin Gülmezoglu* - gulmezoglum@who.int; José Villar - villarj@who.int; Jeremy Grimshaw - jgrimshaw@ohri.ca; 
Gilda Piaggio - piaggiog@who.int; Pisake Lumbiganon - pisake@kku.ac.th; Ana Langer - alanger@popcouncil.org.mx
* Corresponding author    
Abstract
Background: Effective strategies for implementing best practices in low and middle income
countries are needed. RHL is an annually updated electronic publication containing Cochrane
systematic reviews, commentaries and practical recommendations on how to implement evidence-
based practices. We are conducting a trial to evaluate the improvement in obstetric practices using
an active dissemination strategy to promote uptake of recommendations in The WHO Reproductive
Health Library (RHL).
Methods: A cluster randomized trial to improve obstetric practices in 40 hospitals in Mexico and
Thailand is conducted. The trial uses a stratified random allocation based on country, size and type
of hospitals. The core intervention consists of three interactive workshops delivered over a period
of six months. The main outcome measures are changes in clinical practices that are recommended
in RHL measured approximately a year after the first workshop.
Results: The design and implementation of a complex intervention using a cluster randomized trial
design are presented.
Background
There is an increasing recognition of the information
access and management problems of health care workers.
[1] Resolving a clinical problem begins with a search for a
valid systematic review or practice guideline as the most
efficient method of deciding on the best patient care. [2]
Systematic reviews of randomized controlled trials are
widely acknowledged as providing the gold standard evi-
dence base to support decision-making for further
research, policy and practice. Systematic reviews prepared
by the Cochrane Collaboration are published electroni-
cally and have the additional advantage of being updated,
as new evidence becomes available.
The World Health Organization has published The WHO
Reproductive Health Library (RHL) since 1997 in an effort
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to provide access to the most reliable and up-to-date
information to health care workers in developing coun-
tries. [3] This annually updated database includes pre-
dominantly Cochrane systematic reviews that are relevant
to reproductive health problems faced in low-income
countries together with commentaries written by experts
familiar with under-resourced settings, short practical
guidance documents and implementation aids (such as
educational videos) to facilitate the implementation of
recommended practices. RHL is published in English and
Spanish with new topics added and updated topics
revised on an annual basis. The sixth issue of RHL pub-
lished in 2003 contains 79 Cochrane reviews.
Initiatives such as RHL should address some of the infor-
mation access and management difficulties faced by phy-
sicians. However they are unlikely, by themselves, to lead
to significant improvements in performance, as health
care workers have limited time to read reviews and guide-
lines and many changes in behaviour require organisa-
tional changes. There is evidence that passive
dissemination of information is unlikely to lead to
improvements in health care performance. [4] Active
interventions with components ranging from simple
reminders given to clinicians, to complex multi-faceted
interventions have been tested in diverse settings to
improve clinical practices. While there is no single inter-
vention that works under all conditions, most interven-
tions may yield modest to moderate improvements in
some settings. [5] Interventions with several components
(multi-faceted) seem to have a higher chance of improv-
ing practices as more barriers can be addressed and over-
come with different components. [6]
The objective of the study is to evaluate the improvement
in obstetric practices using an active dissemination strat-
egy to promote uptake of recommendations in The WHO
Reproductive Health Library (RHL). We hypothesized that
equipping health care workers with the skills and knowl-
edge to use systematic reviews will improve their practices.
Study settings
Maternity units of hospitals with sufficient number of
deliveries (> 1000 deliveries/year) to enable measurement
of the outcomes, not associated directly with a university
or other academic/research department were eligible to
participate. In Mexico all state and social security hospi-
tals in the Mexico City municipal area were approached.
Twenty-two out of 34 eligible and approached hospitals
participated. In Thailand, all hospitals in the Northeast
province except one agreed to participate in the trial (n =
18). About 2/5ths of Thailand's population lives in the
Northeast province (Figure 1).
The characteristics of the hospitals in the two countries are
quite different (Table 1). In Mexico, the hospitals are all
urban, cosmopolitan, and doctors provide the care to a
large extent. There are two hospital systems, one state hos-
pital system and the social security system. The social
security system has two components providing health care
to formal-sector workers, their families and to govern-
ment workers and their families. We thought that the two
system hospitals (state federal hospitals and social secu-
rity hospitals) may differ somewhat in their characteristics
and response to the intervention and stratified accord-
ingly. In Thailand, the hospitals are in small towns and
midwives usually provide the routine obstetric care. In
general, Thai hospitals have fewer doctors and are without
written guidelines on management of specific obstetric
problems or well-defined continued medical education
programmes.
Methods
Study design
The study has a stratified cluster randomized trial design.
Cluster randomized trials provide both practical and
methodological advantages for implementation studies
especially when the intervention requires policy changes
and the intended effect is at the institutional level. [7]
Some RHL recommended practices require organisational
change (such as policy of allowing companions to women
in labour) and need to be implemented at the hospital
(cluster) level. Cluster randomization using hospitals as
the unit of allocation reduces contamination between
groups. It is easier to deliver the intervention (workshops)
to a group at the hospital level (unit) than to selected indi-
viduals working within the same unit. Also, by focusing
on the whole staff (head of department, consultants,
trainees, and midwives) one can utilise group dynamics
and peer pressure, which may facilitate the adoption of
recommended practices.
Cluster randomized trials, however, are less efficient sta-
tistically than individually randomized trials because the
responses of individuals in a cluster tend to be more sim-
ilar (intracluster) than those individuals in different clus-
ters (intercluster). The sample size required is accordingly
larger and the analysis techniques have to be adjusted by
the level of association among members of the cluster
(intracluster correlation coefficient). [8] However, when
inferences are at the cluster level, 'the study could be
regarded, at least with respect to adopting an approach to
the sample size estimation and analysis, as a standard
clinical trial'. [9]
We collected hospital baseline information on factors
likely to be associated with the outcomes such as the
number of deliveries per year, number of professional
staff relative to size, referral status and the distance toBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/2
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university hospitals. We discussed which of these had to
be controlled for in the design, deciding finally that coun-
try, type and size of hospital captured most of the varia-
tion of these factors.
We then debated whether the design should be a
matched-pair design or a stratified design. In the former,
two hospitals with similar pre-defined characteristics
assumed to be correlated with the outcome are paired and
then one hospital of the pair is randomly allocated to the
intervention, while the other hospital of the pair receives
the control. The stratified design is a generalisation of the
matched-pair design in which hospitals are grouped into
homogeneous groups or strata according to the pre-
defined characteristics, and then they are randomly allo-
cated, within each stratum, to the intervention or the con-
Flow chart of the trial design and random allocation (* In Mexico one hospital in large-social security stratum withdrew after  random allocation (because of building renovation in the maternity) Figure 1
Flow chart of the trial design and random allocation (* In Mexico one hospital in large-social security stratum withdrew after 
random allocation (because of building renovation in the maternity). Another hospital that consented to participate that 
belonged to the small-state stratum was randomized; I = Intervention, C = Control)
40 hospitals included
Stratification
Thailand Mexico*
Large
(n = 6)
Small
(n = 12)
Small 
Social 
Security
(n = 3)
Large 
Social 
Security
(n = 5)
Small 
State
(n = 11)
Large 
State
(n = 3)
Random allocation within strata
I =3
C =3 
I =6
C=6
I =2
C =1 
I =3 
C =2 
I =6
C =5 
I =2
C =1
Intervention group = 22 hospitals
Control group = 18 hospitals
53 hospitals approached
13 declined to participateBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/2
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trol group. The situations in which one or the other design
is better or might be a choice, and which situation pre-
vailed in our study, are described in Table 2.
We decided to use the stratified design because the initial
analysis of hospital characteristics – country and type and
size of hospital – indicated that the gain in power
achieved by matching would not compensate the loss of
power resulting from the reduction in the degrees of free-
dom. This is because the pairs based on these variables
were not very distinct and they were not likely to achieve
more balancing between arms of the potentially impor-
tant factors at baseline than that achieved by the stratified
design. For example, with regard to the annual delivery
rates three of the pairs would be 3000–3000, 3344–3600
and 3600–3743. When the pairs are not clearly distinct as
in our case, pairing would result in a low matching corre-
lation, which is a measure of the (in) effectiveness of
pairing and can be regarded as the standard Pearson cor-
relation computed over the paired clusters. [8]
In addition, we wished to allow for heterogeneity of the
effect across strata (intervention by strata interaction) and
for the possibility of hospital dropouts. The number of
hospitals (40) was reasonably large. Analysis at individual
level was not essential, which would have allowed the
choice of the matched-pair design, but analysis at cluster
level is also compatible with the stratified design.
Finally, the estimation of the intracluster correlation coef-
ficient (ICC) requires an estimate of the between-cluster
and of the within-cluster variance. In a matched-pair
design, the former is completely confounded with the
intervention effect and cannot be estimated without mak-
ing the assumption of no intervention effect or other spe-
cial assumptions. On the other hand, the estimation of
the ICC is straightforward with the stratified design and
we would contribute with ICC estimates for our out-
comes, which would be useful for future experiments in
this field.[9]
After these considerations, we decided on a stratification
by country, type of hospital and size, with six strata over-
all, two in Thailand and four in Mexico (Table 1).
Random allocation
The random allocation sequence was produced centrally
by WHO in Geneva, assigning hospitals at random in each
stratum shown in Table 1 to one of the two arms (inter-
vention or control), in equal numbers. For each stratum,
random permutations were produced using a SAS® ran-
dom number generator, with the starting number taken
Table 1: Hospital strata and characteristics
Country Stratum Type / size Number of 
hospitals
Mean number of 
deliveries (range)/ 
year / hospital
Number of hospitals with 
guidelines available
Number of hospitals with 
continued education 
programme present
Mexico 1 Social security / small 3 3334 (2050–4951) 3 3
2 Social security / large 5 9886 (5964–17670) 5 5
3 State / small 11 3112 (1307–4458) 7 8
4 State / large 3 6428 (5019–7244) 2 2
Thailand 5 State / small 12 3249 (1500–4000) 0 0
6 State / large 6 6688 (5200–10000) 0 0
Table 2: Situations in which the matched-pair design is (or might be) better and those in which the stratified design is (or might be) 
better (shading indicates the situations prevailing in our study)
Matched pairs better Stratified better
Large variation between pairs with respect to baseline risk Within-stratum variation small compared to between-stratum variation
High matching correlation Small matching correlation within strata
No individual level analysis desired Analysis at individual level desired (2) (interactions of interventions with age, gender, 
medical history)
Homogeneity of effect can be assumed across pairs Heterogeneity of effect across strata possible
No drop-outs expected Individual hospitals may drop out
Medium number of clusters (20 to 40, so as to have 10–20 well-matched pairs) Large number of clusters (perhaps >30 or >40 depending on the number of strata)
Calculation of ICC(1) needs special assumptions Calculation of ICC straightforward
(1) ICC – intracluster correlation coefficient (2) Only as secondary analysis in our studyBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/2
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independently for each stratum. The allocation was con-
cealed until knowledge of the assignment was required
operationally to implement the intervention. Thus, coun-
try investigators were informed of the allocation status of
the hospitals after collection of baseline data, when the
first intervention workshop had to be organized.
One hospital was excluded after randomization but
before any intervention was conducted due to the mater-
nity ward renovation which reduced the number of deliv-
eries substantially. Another hospital (that happened to
belong to another stratum) was included and randomized
separately to replace this hospital.
Sample size / power calculation
Since inferences, and therefore the analysis, are at the clus-
ter level, sample size calculations are based on the cluster
as the unit. [8]
The total number of units that could be enrolled within
our collaborators' reach was between 36–40. To calculate
the power we used standard formulae using the hospital
as the unit of analysis, as indicated above. We calculated
that with 40 hospitals we would have 90% power to detect
a decrease in the (end-of-study) rate of use of episiotomy
from 70% to 50% or an increase in the (end-of-study) rate
of use of corticosteroids from 20% to 40% in a one-sided
significance test at 5% level of significance. This calcula-
tion was based on the assumption that the variation in the
prevalence of a practice across hospitals, measured by the
standard deviation, is 20%, equal to the minimum differ-
ence to detect. This was arbitrary, since no baseline data
were available. We used a one-sided significance test
because we thought the intervention could only improve
the rate of use of practices (in a direction corresponding to
the recommendation). Our estimate is conservative
because we assumed a completely randomized (cluster)
design (without stratification), which is likely to require a
larger sample size.
We planned to estimate the prevalence of a practice in a
hospital based on a minimum of 100 women (cluster
size). This number would provide a maximum error of
estimation of 10% using a 95% confidence interval. For
example, we estimated that about 10% of all women
admitted to labour ward would have preterm babies (less
than 37 weeks) and thus be eligible for corticosteroid
administration. Therefore, we needed to collect data from
1000 women to have adequate precision for the hospital
level estimates. For practical reasons we decided to collect
data from 1000 women or for six months whichever is
reached first in each unit.
Intervention
We planned a multifaceted intervention addressing per-
ceived barriers to evidence based practice that included:
meeting with hospital directors before intervention for
their consent and support (to ensure organisational buy
in); provision of the RHL, computers and printer in an
accessible part of the labour ward/department (to ensure
easy access to the RHL); identification of a hospital RHL
coordinator (to help health care workers to use RHL and
to maintain links with the research team in case of prob-
lems); RHL information materials (poster, short print-
outs) (to promote awareness in health care workers); and
a series of interactive workshop delivered by a specialist
(to teach principles of evidence based practice and use of
the RHL). In these complex intervention trials it is impor-
tant to identify all components of the intervention clearly
as much as possible. We wanted to ensure that the inter-
vention would be feasible in routine care settings and
agreed that three workshops spread over a period of six
months would be the maximum intensity intervention
that could be delivered in a non-research setting (i.e.
under normal circumstances). Each workshop had a dif-
ferent focus. Briefly, the first workshop focused on giving
the information about the project, WHO's role, evidence-
based decision-making and the description of RHL. The
second workshop focused on RHL contents and the third
on how to implement change.
Once the intervention was developed then the individuals
to deliver the intervention were identified and trained in
a workshop. The aim of the workshop was to ensure that
in both countries the same standard intervention is fol-
lowed in addition to training in the techniques of the
workshops. We felt that the workshops needed to be con-
ducted by obstetric consultants who would be respected
by staff. The actual implementation was monitored
through workshop checklists. In some large hospitals in
Mexico the same workshop was repeated over a period of
one or two days to capture staff who were in night duty or
were not available for one of the workshops. The consult-
ants were instructed to focus on the use of RHL rather than
going into details of one particular topic. Nevertheless, it
was expected that especially in the second workshops spe-
cific topics would be discussed due to the interactive
nature of the workshops.
The control group did not receive any intervention. Those
hospitals gave consent to participate in the trial and were
told that they would receive the same intervention if the
trial was successful. The computers and printers will be
given to the control hospitals at the end of the trial regard-
less of the results.BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/2
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Co-interventions
Evidence-based medicine was becoming more widely
known during the planning phase of the trial (1999–
2000). We expected that in the study sites there could be
initiatives beyond our control that could influence the
adoption of practices. In Thailand, health sector reforms
and hospital accreditation programmes are being imple-
mented across the country. In Mexico, there is growing
recognition of evidence-based medicine and independent
initiatives to improve obstetric practices are becoming
more common especially in large cities. We hope to
record these developments as much as possible and assess
their effects in exploratory post hoc analyses.
The global passive dissemination of RHL to existing sub-
scribers continued during the trial period in both coun-
tries. We avoided conducting active initiatives such as
training workshops, seminars or presentations at the trial
sites during the trial period.
Outcomes
Outcome measurements are taken at baseline (pre-inter-
vention) and at the end of the study (post-intervention) to
enable baseline performance to be accounted for during
the analysis. Collecting baseline data strengthens the over-
all design of the study by allowing the evaluation of
change in practices over time, assessment of a 'ceiling
effect' in selected practices and assessing the imbalance of
important prognostic variables between groups.
The end-of-study outcome assessments are made at 10–12
months after the first intervention workshop. This period
was chosen arbitrarily but based on the argument that fol-
lowing an intervention delivered in a six-month period, a
change should be demonstrable within the following 3–6
months to assess the effectiveness of the intervention.
Field workers not involved in the implementation of the
trial collected outcome data. The data collection forms
were completed in the postnatal wards mostly from hos-
pital records. The mothers were consulted if there were
missing information in the records. As of October 2003 all
outcome data collection has been completed and data
cleaning/entry are ongoing.
Selection of outcomes
The discussion on the choice of outcomes focused on
measurement of knowledge, physician practices and
health outcomes. If the practices for which increased utili-
zation is important are known to be cost-effective, then it
is not necessary to measure health outcomes when evalu-
ating implementation strategies.[11] Measurement of
knowledge on the other hand is not satisfactory because it
does not relate to change in behaviour, which is the target
of the intervention.
We therefore decided to focus on seven practices for which
there is unequivocal evidence for benefit (or harm) based
on the Cochrane reviews and the commentaries included
in RHL No 4 published in 2001 (available when the inter-
vention was ready to start) (Table 3). These practices are
heterogeneous and range from change of a drug (e.g. oxy-
tocin for active management of the third stage of labour
rather than another agent) to those that require organisa-
tional change within the units (e.g. labour companion-
ship by 'doulas'). Therefore, the potential for change is
likely to be different for different practices.[11]
Analysis plan
The analysis will be based on the hospital as the unit of
analysis. All the units that provide information on out-
comes will be included in the analysis as randomized. It is
anticipated that for some practices the number of events
may be too small to give precise estimates even with the
sample size described above (e.g. magnesium sulfate for
eclampsia).
Means and standard deviations or mean rates of baseline
clinical data, as appropriate, will be calculated by country
and arm. The change between the practice rate at 10–12
months and the baseline rates (before-after) will be calcu-
lated for each hospital. The mean change will be
compared between countries and arms using analysis of
variance techniques, perhaps after transformation of the
proportions to the arcsine or logit or logarithmic transfor-
mation as appropriate. The model for analysis of variance
will include terms for countries, strata within countries,
arm and for significant interactions. Adjusted mean
changes and 95% confidence intervals will be derived
from an appropriate model.
However, the analysis of change has the limitation that
baseline values are likely to be negatively correlated with
change because hospitals with low percentages of a given
desirable practice at baseline might improve more than
hospitals with high percentages. Analysis of covariance
allows the adjustment of the mean rates at 10–12 months
by baseline rates and other baseline variables and has gen-
erally greater power to detect a treatment effect.[12] There-
fore analysis of covariance will be used with covariates at
the cluster level to obtain adjusted mean practice rates by
arm and compare them. Possible confounders to be
included in the analysis of covariance are existing clinical
practice guidelines, continued medical education pro-
gramme and the initial reception of the research team by
the hospital staff. Interactions of arm by country and arm
by strata will be explored, and if found, stratified analyses
will be done. The interaction of arm by baseline will be
examined to assess the validity of the analysis based on
changes from baseline.BMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/2
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The procedure described above will be applied in the anal-
ysis of the seven outcomes described in Table 3. We shall
declare the intervention effective if statistical significance
at the 5% level is demonstrated for the majority (four or
more) of these outcomes. However, we also expect that
the intervention 'holds at least a clinically relevant numer-
ical edge over the control for those primary endpoints for
which demonstration of statistical significance is not
achieved.'[13] It is generally accepted that no adjustment
for multiple endpoints is necessary under this scenario.
[13]
An exploratory analysis will be considered to compare the
practices between the group receiving active dissemina-
tion and the group with no intervention controlling for
individual level covariates.
Nested studies
We conducted a survey of hospital staff to learn their
sources of new information, the time they dedicated to
reading and their knowledge of evidence-based medicine.
We shall conduct interviews with RHL coordinators at the
intervention hospitals and repeat the survey at the end of
the trial to get more in-depth information about their
experiences. We also plan to look at individual hospitals
where certain practices may have been adopted to see if we
can identify any context specific issues. We wish to capture
the dynamics of the workshops and assess the reactions of
the staff to the intervention as well as to the tool.
Each computer has a log file to indicate how many times
the program is accessed. We shall analyse the log files as a
proxy indicator of RHL use in the intervention hospitals,
acknowledging that these may not relate directly to
change in behaviour.
Ethical approval and consent
The study was approved by the Scientific and Ethical
Review Group of the UNDP/UNFPA/WHO/World Bank
Special Programme on Research, Development and
Research Training in Human Reproduction (HRP) and the
participating institutions. Responsible officers of the hos-
pitals and the administrative bodies (i.e. Ministry of
Health) were approached for giving consent to participate
(consent at randomization level). We thought that it
would be ethically permissible for a designated decision-
maker to seek and provide such consent on behalf of his
or her constituents. [14] We did not obtain consent from
patients because the intervention was not delivered to the
patients and the data collection was from the records. The
women were approached only for missing information.
Discussion
Although there is significant body of research in the area
of the practice change, most focus on an intervention to
improve one or two pre-defined practices. It is intuitively
easier to tailor an intervention to change a single practice
as the circumstances surrounding that practice can be
more clearly addressed. There is little evidence about the
effectiveness of strategies to promote the uptake of multi-
ple evidence-based recommendations using resources
such as the RHL in either developed or developing coun-
try settings. Furthermore, trials of complex dissemination
and implementation interventions are much more heter-
ogeneous (in many ways) than biomedical intervention
trials and their results are more difficult to generalise. The
majority of these trials have been conducted in North
American and European settings and it is difficult to
extrapolate the findings to developing countries where
there are likely to be differences in health care delivery,
continued education models and access to information at
public hospitals. The evidence gap for effective implemen-
tation strategies in low and middle-income countries
needs to be addressed.
To our knowledge, this is the first time a comprehensive
electronic tool is used as the core of an educational inter-
vention for health care providers in developing countries.
A similar randomized controlled trial (RCT) was con-
ducted by Wyatt et al. to improve 4 obstetric practices rec-
ommended in the Cochrane Pregnancy & Childbirth
database in the United Kingdom [15]. The intervention
comprised a single visit to the senior obstetrician and
midwife together with the Cochrane database disks and
Table 3: Recommended practices in RHL
Practice Desired outcome
1. External cephalic version at term ↓ breech delivery, ↓ caesarean section
2. Social support during labour ↓ caesarean section, ↑ satisfaction with labour
3. Magnesium sulfate for women with eclampsia ↓ recurrent convulsions
4. Corticosteroids before preterm delivery ↓ neonatal death, respiratory distress syndrome
5. Selected episiotomy for nulliparous women ↓ perineal pain postpartum
6. Active management of the third stage of labour ↓ postpartum haemorrhage
7. Unrestricted breastfeeding on demand ↑ exclusive breastfeedingBMC Medical Research Methodology 2004, 4 http://www.biomedcentral.com/1471-2288/4/2
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an educational video of one of the practices. There was sig-
nificant uptake of practices in both the intervention and
control groups overall. Ventouse delivery increased (com-
pared to the use of forceps) more in the intervention
group but other practices did not follow this pattern. The
timing of the trial coincided with increased recognition of
the Cochrane Pregnancy and Childbirth Group's work in
the U.K. The authors attributed the uptake in the control
group in part to this increased visibility.
Complex intervention trials are becoming increasingly
important as more emphasis is placed on changing pro-
fessional behaviour. The challenges faced in the conceptu-
alisation and the eventual design of these projects are
different from clinical trials. There is a need for a multidis-
ciplinary team working on the study design and the
dynamics of implementing these studies. Clinicians are
usually not familiar with the science and the process of
behaviour change although they are still needed in the tai-
loring of the intervention according to the practices. The
statistical issues are usually more complex and teams with
experience in cluster randomized trials are better placed to
design and implement such trials. The selection of a strat-
ified rather than matched pair design and data collection
at individual level enabling ICC calculation and second-
ary analyses were decisions that were taken after discuss-
ing the pros and cons of each option. The decision to
collect individual data meant that a longer data collection
period was necessary.
Campbell et al. presented a framework for the develop-
ment and evaluation of RCTs of complex interventions
[16,17]. They describe several phases of development
from theory to the implementation of the trial stressing
that the phases do not necessarily follow one another
(theory, modelling, exploratory trial, definitive RCT and
long-term implementation). Our trial did not follow this
framework. The theory and past experience were available
through several systematic reviews in the field. We spent
considerable time in the modelling stage. This was neces-
sary because we had to develop the regimen (i.e. dose,
duration) using judgements. Following the modelling
stage we held a workshop on how to deliver the interven-
tion including role-plays for the specialists who were to
deliver the intervention. In Thailand two and in Mexico
one specialist conducted all workshops. We then pro-
ceeded with the definitive trial. We were aware that the
intervention would be delivered slightly differently in the
two countries as indicated above but thought that they
were similar enough. There were some spontaneous add-
on activities at the centres. For example in Thailand in
order to overcome the language barrier the staff in some
hospitals arranged seminars on specific topics where an
English speaking member of staff translated the docu-
ments on a particular topic and presented in Thai. We
think that differential effects can be expected across hospi-
tals. The additional data collected on workshops and
qualitative analyses will shed more light into the dynam-
ics of change in those particular settings.
The differences in health care delivery systems, the availa-
bility of continuing medical education programmes and
access to evidence-based health care information are
likely to be different in many low-income countries com-
pared to their industrialized counterparts. The other
important aspect of this trial is attempting to equip health
workers with the skills to use evidence-based health care
information. Provision of a regularly updated tool con-
taining the best evidence with information on the rele-
vance of the findings to low-income settings and
implementation tools is an integral part of the implemen-
tation strategy. Strengthening the evidence-base for imple-
mentation interventions in developing countries will
contribute to improvements in standards of care.
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